位置:成果数据库 > 期刊 > 期刊详情页
组蛋白去乙酰化酶抑制剂在多发性骨髓瘤治疗中的研究进展
  • 期刊名称:解放军医学院学报
  • 时间:2013
  • 页码:529-530
  • 分类:R733.73[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]解放军总医院海南分院血液科,海南三亚572013, [2]河南省人民医院肿瘤科,河南郑州450000
  • 相关基金:国家自然科学基金资助项目(81070451/H0813)
  • 相关项目:G-CSF对CD4+T细胞LFA-1活化状态调控的分子机制
中文摘要:

目的通过1例经克拉屈滨治疗的复发毛细胞白血病的病例分析,进一步了解毛细胞白血病的治疗策略和方法。方法观察2012年4月我院收治的1例经克拉屈滨治疗的毛细胞白血病复发患者的治疗过程,分析毛细胞白血病的临床特点、治疗方法、治疗效果及不良反应,并复习有关文献。结果此例患者经1个疗程克拉屈滨治疗,3个月后达到部分缓解,随访5个月持续部分缓解。结论克拉屈滨是治疗毛细胞白血病的有效方法,不良反应小,耐受性好,适合在中国毛细胞白血病患者中应用。

英文摘要:

Objective To study the treatment strategies and methods of hairy cell leukemia (HCL) by analyzing 1 case of relapsed HCL after treated with cladribine. Methods The clinical features, treatment methods and their effect, and adverse reactions of 1 case of relapsed HCL admitted to our hospital in April 2012 and treated with cladribine were analyzed with the related literature reviewed. Results The symptoms of the patient were partially alleviated 3 months after treated with cladribine. The patient was followed up for 5 months during which the symptoms were continuously and partially alleviated. Conclusion Cladribine is effective for HCL with few adverse reactions and good tolerance, and can thus be used in treatment of Chinese HCL patients.

同期刊论文项目
同项目期刊论文